Unihealth Consultancy (NSE:UNIHEALTH) Debt-to-EBITDA : 2.50 (As of Mar. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Unihealth Consultancy Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Unihealth Consultancy's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was ₹35.7 Mil. Unihealth Consultancy's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was ₹357.0 Mil. Unihealth Consultancy's annualized EBITDA for the quarter that ended in Mar. 2023 was ₹156.9 Mil. Unihealth Consultancy's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 was 2.50.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Unihealth Consultancy's Debt-to-EBITDA or its related term are showing as below:

NSE:UNIHEALTH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.5 Med: 3.8 Max: 18.66
Current: 2.5

During the past 4 years, the highest Debt-to-EBITDA Ratio of Unihealth Consultancy was 18.66. The lowest was 2.50. And the median was 3.80.

NSE:UNIHEALTH's Debt-to-EBITDA is ranked better than
51.64% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 2.645 vs NSE:UNIHEALTH: 2.50

Unihealth Consultancy Debt-to-EBITDA Historical Data

The historical data trend for Unihealth Consultancy's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unihealth Consultancy Debt-to-EBITDA Chart

Unihealth Consultancy Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Debt-to-EBITDA

18.66

4.53

3.07

2.50

Unihealth Consultancy Semi-Annual Data
	Mar20	Mar21	Mar22	Mar23
Debt-to-EBITDA	18.66	4.53	3.07	2.50

Competitive Comparison of Unihealth Consultancy's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Unihealth Consultancy's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unihealth Consultancy's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Unihealth Consultancy's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Unihealth Consultancy's Debt-to-EBITDA falls into.

Unihealth Consultancy Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Unihealth Consultancy's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(35.713	+	356.954)	/	156.868
	=	2.50

Unihealth Consultancy's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(35.713	+	356.954)	/	156.868
	=	2.50

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Mar. 2023) EBITDA data.

Unihealth Consultancy (NSE:UNIHEALTH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Unihealth Consultancy Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Unihealth Consultancy's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Unihealth Consultancy (NSE:UNIHEALTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Unihealth Consultancy Ltd (NSE:UNIHEALTH) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

156 Tardeo Road, H-13 & H-14, Everest , 9th Floor, Mumbai, MH, IND, 400034

Website

https://www.unihealthonline.com

Unihealth Consultancy Ltd is a healthcare service provider based out of Mumbai, India and has an operational presence in multiple countries across the African continent. Its business segments include Medical Centres, Hospitals, Consultancy Services, Distribution of Pharmaceutical & Medical Consumable Products and Medical Value Travel. It is currently providing Project Management Consultancy Services to set up a 300+ bedded Health City in Undri, Pune (Maharashtra, India) for PHRC Lifespaces Organization along with a few other healthcare consultancy projects in Kenya and Angola. The Majority of revenue is derived from Uganda.

Unihealth Consultancy (NSE:UNIHEALTH) Headlines

No Headlines